Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

7.236 -0.054 (-0.74%)

Streaming Delayed Price Updated: 2:49 PM EDT, Apr 27, 2026 Add to My Watchlist

Price and Volume

Volume	349,586
Open	7.350
Bid (Size)	7.230 (200)
Ask (Size)	7.240 (400)
Prev. Close	7.290
Today's Range	7.230 - 7.650
52wk Range	0.4700 - 8.246
Shares Outstanding	14,508,063
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on

March 18, 2026

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

March 16, 2026

From Grabar Law Office

Via GlobeNewswire

Performance

YTD	+24.8%	+24.8%
1 Month	+13.2%	+13.2%
3 Month	+5.2%	+5.2%
6 Month	+38.1%	+38.1%
1 Year	+1015.6%	+1015.6%

More News

Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on

March 12, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims

March 10, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your

March 05, 2026

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

December 03, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims

December 02, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 14, 2025

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 10, 2025

From Grabar Law Office

Via GlobeNewswire

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 31, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

October 27, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of CS Disco Inc. (NYSE: LAW); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

October 24, 2025

From Grabar Law Office

Via GlobeNewswire

UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

October 14, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

October 13, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Unicycive to Contact the Firm Before the October 14th Deadline in the Filed Class Action Lawsuit

October 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

October 12, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY

October 10, 2025

Via NewMediaWire

Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY

October 10, 2025

Via TheNewswire.com

UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges Investor to Contact the Firm Before the October 14th Deadline

October 10, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders

October 09, 2025

Via NewMediaWire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders

October 09, 2025

Via TheNewswire.com

UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

October 08, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

October 08, 2025

From Grabar Law Office

Via GlobeNewswire

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?

Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?

Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?

The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market

What is the current price of Unicycive Therapeutics, Inc. - Common Stock?

The current price of Unicycive Therapeutics, Inc. - Common Stock is 7.236

When was Unicycive Therapeutics, Inc. - Common Stock last traded?

The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 04/27/26 02:49 PM ET

What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?

The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 104.98M

How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?

Unicycive Therapeutics, Inc. - Common Stock has 105M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.